BANK OF AMERICA CORP /DE/ - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 25 filers reported holding XENON PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$5,549,518
-17.9%
142,332
-9.4%
0.00%
-100.0%
Q1 2024$6,763,328
-41.3%
157,104
-37.2%
0.00%
-50.0%
Q4 2023$11,529,371
+172.3%
250,312
+101.9%
0.00%
Q3 2023$4,234,712
-31.0%
123,967
-22.2%
0.00%
-100.0%
Q2 2023$6,135,977
+27.8%
159,376
+18.8%
0.00%
Q1 2023$4,799,833
+37.2%
134,111
+51.1%
0.00%
Q4 2022$3,499,334
+259.3%
88,748
+228.8%
0.00%
Q3 2022$974,000
-12.6%
26,995
-26.4%
0.00%
Q2 2022$1,115,000
+480.7%
36,655
+483.8%
0.00%
Q1 2022$192,000
-85.6%
6,279
-85.3%
0.00%
Q4 2021$1,337,000
+507.7%
42,798
+197.5%
0.00%
Q3 2021$220,000
+69.2%
14,387
+106.1%
0.00%
Q2 2021$130,000
-57.9%
6,979
-59.6%
0.00%
Q1 2021$309,000
+602.3%
17,272
+504.3%
0.00%
Q4 2020$44,000
+18.9%
2,858
-14.5%
0.00%
Q3 2020$37,000
-15.9%
3,343
-5.3%
0.00%
Q2 2020$44,000
+29.4%
3,530
+34.8%
0.00%
Q4 2019$34,0002,618
+4839.6%
0.00%
Q2 2019$0
-100.0%
53
-35.4%
0.00%
Q1 2019$1,000
-87.5%
82
-93.8%
0.00%
Q4 2018$8,000
-55.6%
1,329
-39.1%
0.00%
Q3 2015$18,000
-64.7%
2,182
-28.1%
0.00%
Q1 2015$51,000
-15.0%
3,0330.0%0.00%
Q4 2014$60,0003,0330.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,754,266$107,388,8317.33%
Altium Capital Management LP 360,600$14,059,7945.74%
Affinity Asset Advisors, LLC 994,227$38,764,9114.47%
First Light Asset Management, LLC 1,306,260$50,931,0774.46%
Nan Fung Group Holdings Ltd 106,680$4,159,4534.44%
Ally Bridge Group (NY) LLC 169,369$6,603,6973.93%
TLS Advisors LLC 32,956$1,2853.22%
BRAIDWELL LP 2,560,573$99,836,7413.13%
Paradigm Biocapital Advisors LP 2,043,280$79,667,4873.05%
BRIDGER MANAGEMENT, LLC 146,800$5,723,7322.94%
View complete list of XENON PHARMACEUTICALS INC shareholders